Which decade in the history of filmmaking — a history dating back more than a century — produced the most great movies? Last year, the BBC made a case for the 1920s, the decade that saw...
Which decade in the history of filmmaking — a history dating back more than a century — produced the most great movies? Last year, the BBC made a case for the 1920s, the decade that saw...
Many different genres of movies were popular in the 1960s, including historical epics, westerns, spy dramas, crime capers, and comedies. It was the decade that gave us the first James Bond movies —...
By David Callaway, Callaway Climate Insights SAN FRANCISCO (Callaway Climate Investors) — “It’ll be a dry St. Patrick’s Day during a global pandemic when I ever start another business.”...
With the first quarter soon coming to an end, now is the time to move from momentum to strong growth stocks. Goldman Sachs feels these four could offer extra strength in a pricey stock market.
Many different genres of movies were popular in the 1960s, including historical epics, westerns, spy dramas, crime capers, and comedies. It was the decade that gave us the first James Bond movies...
By David Callaway, Callaway Climate Insights When we launched Callaway Climate Insights 10 months ago, at the start of the pandemic, we promised a new voice in the climate change world, dedicated...
By David Callaway, Callaway Climate Insights Wildfires and hurricanes over the summer drove the news cycle, but environmental, social and governance stocks helped steer the stock market to tidy...
Credit Suisse has set an Outperform rating and $290 price target on Amgen shares. That target implies more than 20% upside to the stock's recent trading price.
These four top Jefferies growth stock picks all offer investors strength in their specific industries and the ability to generate some significant portfolio alpha.
Monday's top analyst upgrades, downgrades and initiations included Adobe, Chevron, Dow, JD.com, Lululemon, 3M, Macy's, Nucor, PNC, RH, RingCentral, WingStop and Zillow.
Amgen is set to report its most recent quarterly results after the closing bell on Tuesday. Wall Street expectations are muted.
Amgen shares dropped on Monday after the firm released additional data from its early-stage lung cancer study. Specifically this data is coming from the ongoing Phase 1 study evaluating AMG 510 in...
This is known as the world’s largest clinical cancer conference, and it always delivers new results on clinical trials and updated treatments in the field. Not to mention, this conference has the...
Abstracts have been released for the companies presenting at the American Association for Cancer Research annual meeting, and Wedbush has some ideas for what the big movers could be.